Mustafa Taner BOSTANCI, Tanju TÜTÜNCÜ, Ceyda Ozhan CAPARLAR, Ozcem OFKELİ, Aziz BULUT, Mehmet Ali CAPARLAR

Long term satisfaction of patients after surgery for primary hyperparathyroidism: Analysis of 71 patients

Amaç: Çalışmanın amacı primer hiperparatiroidism nedeniyle paratiroidektomi yapılmış semptomatik ve asemptomatik hastaların uzun dönem sonuçlarını ve memnuniyetlerini değerlendirerek cerrahinin gerekliliğini tartışmaktır. Yöntem: Retrospektif çalışmamıza Haziran 1999 ile Eylül 2010 tarihleri arasında primer paratiroid patolojisi nedeniyle veya eşlik eden paratiroid patolojisi olup tiroid cerrahisi esnasında paratiroidektomi yapılan hastalar dahil edilmiştir. Toplam 71 hasta çalışmaya dahil edilmiştir ve hastalara The Pasieka Symptom Scoring System ve SF-36 anketleri uygulanmıştır. Hastalar semptomatik ve asemptomatik olmak üzere iki gruba ayrılmıştır. The Pasieka Symptom Scoring System anketinin son 5 sorusunun yanıtları asemptomatik ve semptomatik hastalar arasında genel sağlık durumu, cerrahi memnuniyet ve hayat kalitesini değerlendirmektedir. Bulgular: Semptomatik hastaların sayısı 38 (%53.5) iken 33 (%46.5) hasta asemptomatik grupta idi. Ortalama takip süresi 60 aydı. 71 Hasta arasından 67 hastada (%94.4) kür sağlandı, 4 hastada (%5.6) persistan hiperparatiroidism gelişti ve 2 hasta tekrar opere edildi; 2 hasta ise izlem dışı kaldı. Sonuç: Asemptomatik primer hiperparatiroidismli hastalarda nörokognitif ve psikiatrik yakınmalar maskelenebilir ve bu hastaların yaşam kaliteleri cerrahi ile iyileştirilebilir

Primer hiperparatiroidizm cerrahisi sonrası hastaların uzun dönem memnuniyeti: 71 hastanın analizi

Objective: The aim of this study is to discuss the necessity of surgery by analysing the long term results and satisfaction of the symptomatic and asymptomatic patients who had parathyroidectomy for primary hyperparathyroidism. Method: Patients who had parathyroidectomy because of primary parathyroid pathology or during thyroid surgery as concomittant parathyroid pathology between June 1999 and September 2010 were enrolled to the present, retrospective study. A total of seventy one patient were included to the study. The Pasieka Symptom Scoring System and SF-36 questionnaire are applied to the patients. The patients were divided into two groups as symptomatic and asympyomatic. The answers to the Pasieka Symptom Scoring System's last 5 questions examining general health, surgical satisfaction and quality of life were evaluated between symptomatic and asymptomatic patients. Results: Number of the symptomatic patients were 38 (53.5%) whereas 33 patients (46.5%) were asymptomatic. Average length of follow up was 60 months. Among the operated 71 patients; 67 (94.4%) were cured, 4 (5.6%) had persistent hyperparathyroidism and 2 of these patients were operated again, the other two patients were out of follow up. Conclusions: Asymptomatic patients with primary hyperparathyroidism may have masked neurocognitive and psychiatric complaints and these patients' quality of life can be improved with surgery.

PDF

___

Özarmağan S. Parathyroid Diseases. Basic and Clinical Sciences 2002; 1: 467-9.
Şanal S, Süslü AE. Primary Hyperparathyroi- dism and Surgical Therapy. ENT Forum 2009; 3: 8.
Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, Krzywda B. Patient- based surgical outcome tool demonstrating alleviation of symptoms following parathyroi- dectomy in patients with primary hyperparathyroidism. World J Surg 2002; 26: 942-9.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.Med Care1992; 30: 473-83.
Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroi-dism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 2009; 94: 335-9.
Bilezikian JP, Potts JT, Fuleihan G, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA. Summary statement from a workshop on asymptomatic primary hyperparathyroi-dism: a perspective for the 21st century. Journal of Clininical Endocrinology &Metabolism 2002; 87: 5353-61.
Bayraktar M. Asemptomatik hiperparatiroi- dizmde cerrahi gerekli mi ?. Yeni Tıp Dergisi 2000; 17: 6-7.
O'Boyle CA. Assessment of quality of life in surgery. Br. J. Surg 1992; 79: 395-8.
Koçyiğit H, Aydemir Ö, Fişek G. Kısa Form (KF-36)'nın Türkçe Versiyonunun Güvenir- liliği ve Geçerliliği. İlaç ve Tedavi Dergisi 1999; 12: 102-6.
Flint RS, Harman CR, Carter J, Snyman G. Primary hyperparathyroidism: referral patterns and outcomes of surgery. ANZ J Surg 2002; 72: 200-3.
Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 2008; 93: 3462-70.
Purnell DC, Smith LH, Scholz DA, Elveback LR. Primary hyperparathyroidism: a prospective clinical study. Am J Med 1971; 50: 670-8.
Kouvaraki MA, Greer M, Sharma S, Beery D, Armand R, Lee JE, Evans DB, Perrier ND. Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. Surgery 2006; 139: 527-34.
Bollerslev J, Jansson S, Mollerup CL. Medical observation, Compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007; 1687-92.